Related references
Note: Only part of the references are listed.Benzalkonium chloride induces anterior chamber inflammation in previously untreated patients with ocular hypertension as measured by flare meter: a randomized clinical trial
Anna M. Stevens et al.
ACTA OPHTHALMOLOGICA (2012)
Comparison of a travoprost BAK-free formulation preserved with polyquaternium-1 with BAK-preserved travoprost in ocular hypertension or open-angle glaucoma
Stefano Gandolfi et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2012)
Long-term Effect of BAK-free Travoprost on Ocular Surface and Intraocular Pressure in Glaucoma Patients After Transition From Latanoprost
Makoto Aihara et al.
JOURNAL OF GLAUCOMA (2012)
The effect of prostaglandin analogues on central corneal thickness of patients with chronic open-angle glaucoma: a 2-year study on 129 eyes
Maria Bafa et al.
ACTA OPHTHALMOLOGICA (2011)
Comparative In Vitro Toxicology Study of Travoprost Polyquad-preserved, Travoprost BAK-preserved, and Latanoprost BAK-preserved Ophthalmic Solutions on Human Conjunctival Epithelial Cells
Francoise Brignole-Baudouin et al.
CURRENT EYE RESEARCH (2011)
In Vitro Comparative Toxicology of Polyquad-Preserved and Benzalkonium Chloride-Preserved Travoprost/Timolol Fixed Combination and Latanoprost/Timolol Fixed Combination
Francoise Brignole-Baudouin et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2011)
Effectiveness of ophthalmic solution preservatives: a comparison of latanoprost with 0.02% benzalkonium chloride and travoprost with the sofZia preservative system
Gerard Ryan et al.
BMC OPHTHALMOLOGY (2011)
Effects of switching to SofZia-preserved travoprost in patients who presented with superficial punctate keratopathy while under treatment with latanoprost
Sei Yamazaki et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2010)
Ocular Surface Tolerability of Prostaglandin Analogs in Patients with Glaucoma or Ocular Hypertension
Jess T. Whitson et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2010)
In Vitro Toxicity of Topical Ocular Prostaglandin Analogs and Preservatives on Corneal Epithelial Cells
Malik Y. Kahook et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2010)
Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials
F. Honrubia et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Ocular preservatives: associated risks and newer options
Indu Pal Kaur et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2009)
Pharmacokinetics, efficacy and safety profiles of preserved and preservative-free tafluprost in healthy volunteers
Hannu Uusitalo et al.
ACTA OPHTHALMOLOGICA (2008)
Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears
Malik Y. Kahook et al.
CORNEA (2008)
In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line
Emmanuelle Brasnu et al.
CURRENT EYE RESEARCH (2008)
Duration of IOP reduction with travoprost BAK-free solution
Ronald L. Gross et al.
JOURNAL OF GLAUCOMA (2008)
Prevalence of ocular surface disease in glaucoma patients
Eamon W. Leung et al.
JOURNAL OF GLAUCOMA (2008)
Efficacy and Tolerability of Prostaglandin Analogs A Meta-analysis of Randomized Controlled Clinical Trials
Florent Aptel et al.
JOURNAL OF GLAUCOMA (2008)
Impression cytology with scanning electron microscopy: a new method in the study of conjunctival microvilli
G. L. Cennamo et al.
EYE (2008)
Efficacy and safety of a systematic switch from latanoprost to travoprost in patients with glaucoma
Rajesh S. Kumar et al.
JOURNAL OF GLAUCOMA (2007)
In vitro studies of antiglaucomatous prostaglandin analogues: Travoprost with and without benzalkonium chloride and preserved latanoprost
Christophe Baudouin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Travoprost 0.004% with and without benzalkonium chloride: A comparison of safety and efficacy
Richard A. Lewis et al.
JOURNAL OF GLAUCOMA (2007)
Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system
Richard W. Yee et al.
ADVANCES IN THERAPY (2006)
Intraocular pressure-lowering effects of all commonly used glaucoma drugs - A meta-analysis of randomized clinical trials
R van der Valk et al.
OPHTHALMOLOGY (2005)
In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells
JM Guenoun et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Corneal epithelial cellular dysfunction from benzalkonium chloride (BAC) in vitro
SH Cha et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2004)
Inhibitory effects of anti-glaucoma drugs on corneal epithelial migration in a rabbit organ culture system
S Hirano et al.
JOURNAL OF GLAUCOMA (2004)
Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost
WC Stewart et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2003)
Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication
PJ Pisella et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Share Paper
